Save New Eucrisa as an Eczema Option After Topical Steroids
The new Eucrisa (you-KRIS-ah, crisaborole) ointment will raise questions about how to manage eczema.
Eucrisa is the first new drug approved for eczema in over a decade. It inhibits phosphodiesterase 4...an enzyme that promotes inflammation.
Think of Eucrisa as a possible second-line med option for mild to moderate eczema...after topical corticosteroids.